Increased risk of myocardial infarction with dabigatran etexilate: fact or fiction? A critical meta-analysis of over 580,000 patients from integrating randomized controlled trials and real-world studies

The question of whether the use of dabigatran etexilate is associated with a high risk of myocardial infarction (MI) remains unanswered owing to the lack of critical evidences.

Source: International Journal of Cardiology - May 18, 2018 Category: Cardiology Authors: An-Hua Wei, Zhi-Chun Gu, Chi Zhang, Yu-Feng Ding, Dong Liu, Juan Li, Xiao-Yan Liu, Hou-Wen Lin, Jun Pu Source Type: research